+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test (TST, IGRA), Application, End Use (Diagnostic Laboratories, Hospitals/Clinics) and Region with Growth Forecasts, 2025-2033- Product Image
Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test (TST, IGRA), Application, End Use (Diagnostic Laboratories, Hospitals/Clinics) and Region with Growth Forecasts, 2025-2033- Product Image
New

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test (TST, IGRA), Application, End Use (Diagnostic Laboratories, Hospitals/Clinics) and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 5702185
REQUEST CUSTOMIZATION
Description Jump to:
The global latent tuberculosis infection detection market size was estimated at USD 1.91 billion in 2024, and is projected to reach USD 3.16 billion by 2033, growing at a CAGR of 5.81% from 2025 to 2033. The growth of the market is attributed to the increasing risk of developing active tuberculosis and the growing awareness among people to diagnose tuberculosis infection at an early stage.

Moreover, ongoing government initiatives to combat the threat of tuberculosis and the increasing introduction of novel diagnostic solutions are anticipated to fuel the latent tuberculosis infection (LTBI) detection market growth. Individuals with LTBI face a lifetime risk of reactivation, which is expected to be around 5% to 15%, with the majority of the population developing TB within the first 5 years. For those with LTBI, untreated HIV infection and no LTBI treatment can lead to a high risk of about 7%-10% per year, emphasizing the importance of timely intervention. In addition, most TB cases in the U.S. result from the progression of LTBI acquired over 2 years ago, highlighting the significance of addressing LTBI to prevent future cases.

The increasing funding for TB diagnosis programs is crucial in the fight against this global disease. The current funding for prevention, diagnosis, and treatment is insufficient to meet the demand, hindering progress in reducing incidence & mortality rates. For instance, an annual investment of USD 22 billion by 2027 was set, with an additional USD 5 billion for research, and only USD 5.8 billion was allocated for TB services, falling short of the required amounts to achieve global targets. Moreover, WHO emphasizes the need for sustained & increased funding to combat TB effectively.

Hence, the U.S. government has significantly increased its funding for TB initiatives, from USD 233 million in 2013 to USD 406 million in 2023. Investments in screening and preventive treatment have shown significant health & economic benefits, with a return on investment of up to USD 39 for every dollar spent. Hence, expanding investments in TB diagnosis programs is essential to improve access to diagnosis, treatment, and prevention to eliminate the TB epidemic by 2033. Moreover, the Global Fund contributes 76% of total international funding for TB, having allocated USD 9.2 billion toward prevention & treatment programs and an extra USD 1.5 billion for TB/HIV initiatives by June 2023. In countries receiving support from the Global Fund, TB-related fatalities have decreased by 36% from 2002 to 2022.

Moreover, the increasing number of elderly individuals worldwide poses a major hurdle in the control of TB within this age group. The rates of TB case detection & incidence are particularly high among older adults, emphasizing the importance of incorporating specific measures in TB response strategies to address their increased risk. In the Western Pacific, where the population is aging rapidly, there has been a notable increase in TB cases among older individuals, propelling the need for customized approaches to diagnosis, treatment, and care for this vulnerable demographic. This is expected to improve the need for the development of effective & efficient diagnostics to meet the rising demand for management among older populations.

However, the regulatory framework for approvals poses major restraints on the growth rate of the pharmaceutical, biotechnology, and medical technology industries. Globally, usage & safety profiles of diagnostic tests vary and are evaluated by health regulatory agencies of each country differently. This makes the approval of novel products slower.

Global Latent Tuberculosis Infection Detection Market Report Segmentation

This report forecasts revenue & volume growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the latent tuberculosis infection detection market report based on brand, test, application, end use, and region:
  • Brand Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021-2033)
  • QFT-Plus (QuantiFERON-TB Gold Plus)
  • Others
  • Test Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021-2033)
  • Tuberculin Skin Test (TST)
  • Interferon Gamma Released Assay (IGRA)
  • Application Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021-2033)
  • Household Contacts with Pulmonary TB
  • PLHIV
  • Others
  • End Use Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021-2033)
  • Diagnostic Laboratories
  • Hospitals/Clinics
  • Academic & Research Institutions
  • Regional Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021-2033)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Latent Tuberculosis Infection Detection Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Method
1.1.1.2. Test Segment
1.1.1.3. Application Segment
1.1.1.4. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Latent Tuberculosis Infection Detection Market: Executive Summary
2.1. Market Snapshot
2.2. Brand Snapshot
2.3. Test Snapshot
2.4. End Use Snapshot
2.5. Application Snapshot
2.6. Competitive Landscape Snapshot
Chapter 3. Latent Tuberculosis Infection Detection Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Increasing risk of developing active tuberculosis infection from LTBI
3.4.2. Increasing funding programs to promote TB diagnosis
3.4.3. Favorable government initiatives for combating TB
3.4.4. Surge in geriatric population
3.5. Market Restraint Analysis
3.5.1. Presence of stringent rules and regulations pertaining to diagnosis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Latent Tuberculosis Infection Detection Market: Brand Estimates & Trend Analysis
4.1. Global Latent Tuberculosis Infection Detection Market: Brand Dashboard
4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis
4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue
4.4. QFT-Plus (QuantiFERON-TB Gold Plus)
4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
4.5. Others
4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
Chapter 5. Latent Tuberculosis Infection Detection Market: Test Estimates & Trend Analysis
5.1. Global Latent Tuberculosis Infection Detection Market: Test Dashboard
5.2. Global Latent Tuberculosis Infection Detection Market: Test Movement Analysis
5.3. Global Latent Tuberculosis Infection Detection Market by Test, Revenue
5.4. Tuberculin Skin Test (TST)
5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
5.5. Interferon Gamma Released Assay (IGRA)
5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
Chapter 6. Latent Tuberculosis Infection Detection Market: Application Estimates & Trend Analysis
6.1. Global Latent Tuberculosis Infection Detection Market: Application Dashboard
6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis
6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue
6.4. Household Contacts with Pulmonary TB
6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
6.5. PLHIV
6.5.1. PLHIV market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
6.6. Others
6.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
Chapter 7. Latent Tuberculosis Infection Detection Market: End Use Estimates & Trend Analysis
7.1. Global Latent Tuberculosis Infection Detection Market: End Use Dashboard
7.2. Global Latent Tuberculosis Infection Detection Market: End Use Movement Analysis
7.3. Global Latent Tuberculosis Infection Detection Market by End Use, Revenue
7.4. Diagnostic Laboratories
7.4.1. Diagnostic laboratories market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
7.5. Hospitals/Clinics
7.5.1. Hospitals/Clinics market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
7.6. Academic & Research Institutions
7.6.1. Academic & research institutions market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
Chapter 8. Latent Tuberculosis Infection Detection Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End Use
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.9. Netherlands
8.4.9.1. Key country dynamics
8.4.9.2. Regulatory framework/ reimbursement structure
8.4.9.3. Competitive scenario
8.4.9.4. Netherlands market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.10. Belgium
8.4.10.1. Key country dynamics
8.4.10.2. Regulatory framework/ reimbursement structure
8.4.10.3. Competitive scenario
8.4.10.4. Belgium market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.11. Finland
8.4.11.1. Key country dynamics
8.4.11.2. Regulatory framework/ reimbursement structure
8.4.11.3. Competitive scenario
8.4.11.4. Finland market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.12. Luxembourg
8.4.12.1. Key country dynamics
8.4.12.2. Regulatory framework/ reimbursement structure
8.4.12.3. Competitive scenario
8.4.12.4. Luxembourg market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.4.13. Iceland
8.4.13.1. Key country dynamics
8.4.13.2. Regulatory framework/ reimbursement structure
8.4.13.3. Competitive scenario
8.4.13.4. Iceland market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5. Asia-Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5.7. Singapore
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.5.8. Bangladesh
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Bangladesh market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. QIAGEN
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. BIOMÉRIEUX
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Oxford Immunotec
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. SD Biosensor, INC.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Wantai BioPharm
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Lionex GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Sanofi
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Serum Institute of India Pvt. Ltd
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. ARKRAY, Inc.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Par Pharmaceutical, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
List of Tables
TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 North America latent tuberculosis infection detection market, by country, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 4 North America latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 5 North America latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 6 North America latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 7 North America latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 8 U.S. latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 9 U.S. latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 10 U.S. latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 11 U.S. latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 12 Canada latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 13 Canada latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 14 Canada latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 15 Canada latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 16 Mexico latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 17 Mexico latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 18 Mexico latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 19 Mexico latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 20 Europe latent tuberculosis infection detection market, by country, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 21 Europe latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 22 Europe latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 23 Europe latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 24 Europe latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 25 UK latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 26 UK latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 27 UK latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 28 UK latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 29 Germany latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 30 Germany latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 31 Germany latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 32 Germany latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 33 France latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 34 France latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 35 France latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 36 France latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 37 Italy latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 38 Italy latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 39 Italy latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 40 Italy latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 41 Spain latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 42 Spain latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 43 Spain latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 44 Spain latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 45 Denmark latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 46 Denmark latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 47 Denmark latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 48 Denmark latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 49 Sweden latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 50 Sweden latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 51 Sweden latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 52 Sweden latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 53 Norway latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 54 Norway latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 55 Norway latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 56 Norway latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 57 Netherlands latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 58 Netherlands latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 59 Netherlands latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 60 Netherlands latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 61 Belgium latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 62 Belgium latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 63 Belgium latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 64 Belgium latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 65 Sweden latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 66 Sweden latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 67 Sweden latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 68 Sweden latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 69 Finland latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 70 Finland latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 71 Finland latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 72 Finland latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 73 Denmark latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 74 Denmark latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 75 Denmark latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 76 Denmark latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 77 Luxembourg latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 78 Luxembourg latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 79 Luxembourg latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 80 Luxembourg latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 81 Iceland latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 82 Iceland latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 83 Iceland latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 84 Iceland latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 85 Rest of Europe latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 86 Rest of Europe latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 87 Rest of Europe latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 88 Rest of Europe latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 89 Asia-Pacific latent tuberculosis infection detection market, by country, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 90 Asia-Pacific latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 91 Asia-Pacific latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 92 Asia-Pacific latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 93 Asia-Pacific latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 94 Japan latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 95 Japan latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 96 Japan latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 97 Japan latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 98 South Korea latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 99 South Korea latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 100 South Korea latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 101 South Korea latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 102 Australia latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 103 Australia latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 104 Australia latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 105 Australia latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 106 India latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 107 India latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 108 India latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 109 India latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 110 Singapore latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 111 Singapore latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 112 Singapore latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 113 Singapore latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 114 Bangladesh latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 115 Bangladesh latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 116 Bangladesh latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 117 Bangladesh latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 118 Rest of Asia-Pacific latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 119 Rest of Asia-Pacific latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 120 Rest of Asia-Pacific latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 121 Rest of Asia-Pacific latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 122 Latin America latent tuberculosis infection detection market, by country, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 123 Latin America latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 124 Latin America latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 125 Latin America latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 126 Latin America latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 127 Brazil latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 128 Brazil latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 129 Brazil latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 130 Brazil latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 131 Rest of the LATAM latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 132 Rest of the LATAM latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 133 Rest of the LATAM latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 134 Rest of the LATAM latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 135 MEA latent tuberculosis infection detection market, by country, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 136 MEA latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 137 MEA latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 138 MEA latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 139 MEA latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 140 Saudi Arabia latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 141 Saudi Arabia latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 142 Saudi Arabia latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 143 Saudi Arabia latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 144 Rest of MEA latent tuberculosis infection detection market, by brand, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 145 Rest of MEA latent tuberculosis infection detection market, by test, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 146 Rest of MEA latent tuberculosis infection detection market, by application, 2021-2033 (USD Million, Volume in Thousand Tests)
TABLE 147 Rest of MEA latent tuberculosis infection detection market, by end use, 2021-2033 (USD Million, Volume in Thousand Tests)
List of Figures
Figure 1 Latent Tuberculosis Infection Detection Market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment.
Figure 8 Market formulation & validation
Figure 9 Latent Tuberculosis Infection Detection Market snapshot
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Penetration and growth prospect mapping
Figure 13 Latent tuberculosis infection detection market: Brand movement analysis
Figure 14 Latent tuberculosis infection detection market: Brand outlook and key takeaways
Figure 15 QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 16 Others estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 17 Latent tuberculosis infection detection market: Test movement analysis
Figure 18 Latent tuberculosis infection detection market: Test outlook and key takeaways
Figure 19 Tuberculin Skin Test (TST) market estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 20 Interferon Gamma Released Assay (IGRA) estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 21 Latent tuberculosis infection detection market: Application movement analysis
Figure 22 Latent tuberculosis infection detection market: Application outlook and key takeaways
Figure 23 Household contacts with pulmonary TB market estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 24 PLHIV estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 25 Others estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 26 Latent tuberculosis infection detection market: End Use movement analysis
Figure 27 Latent tuberculosis infection detection market: End Use outlook and key takeaways
Figure 28 Diagnostics laboratories estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 29 Hospital/Clinics market estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 30 Academic & research institutions market estimates and forecast, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 31 Global latent tuberculosis infection detection market: Regional movement analysis
Figure 32 Global latent tuberculosis infection detection market: Regional outlook and key takeaways
Figure 33 Global latent tuberculosis infection detection market share and leading players
Figure 34 North America, by country
Figure 35 North America market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 36 U.S. key country dynamics
Figure 37 U.S. market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 38 Canada key country dynamics
Figure 39 Canada market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 40 Europe market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 41 UK key country dynamics
Figure 42 UK market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 43 Germany key country dynamics
Figure 44 Germany market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 45 France key country dynamics
Figure 46 France market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 47 Italy key country dynamics
Figure 48 Italy market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 49 Spain key country dynamics
Figure 50 Spain market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 51 Denmark key country dynamics
Figure 52 Denmark market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 53 Sweden key country dynamics
Figure 54 Sweden market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 55 Norway key country dynamics
Figure 56 Norway market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 57 Netherlands key country dynamics
Figure 58 Netherlands market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 59 Belgium key country dynamics
Figure 60 Belgium market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 61 Finland key country dynamics
Figure 62 Finland market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 63 Luxembourg key country dynamics
Figure 64 Luxembourg market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 65 Iceland key country dynamics
Figure 66 Iceland market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 67 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 68 China key country dynamics
Figure 69 China market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 70 Japan key country dynamics
Figure 71 Japan market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 72 India key country dynamics
Figure 73 India market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 74 Thailand key country dynamics
Figure 75 Thailand market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 76 South Korea key country dynamics
Figure 77 South Korea market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 78 Australia key country dynamics
Figure 79 Australia market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 80 Singapore key country dynamics
Figure 81 Singapore market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 82 Bangladesh key country dynamics
Figure 83 Bangladesh market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 84 Latin America market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 85 Brazil key country dynamics
Figure 86 Brazil market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 87 Mexico key country dynamics
Figure 88 Mexico market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 89 Argentina key country dynamics
Figure 90 Argentina market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 91 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 92 South Africa key country dynamics
Figure 93 South Africa market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 94 Saudi Arabia key country dynamics
Figure 95 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 96 UAE key country dynamics
Figure 97 UAE market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 98 Kuwait key country dynamics
Figure 99 Kuwait market estimates and forecasts, 2021-2033 (USD Million, Volume in Thousand Tests)
Figure 100 Market share of key market players- Latent tuberculosis infection detection market

Companies Mentioned

The key companies profiled in this Latent Tuberculosis Infection Detection market report include:
  • QIAGEN
  • BIOMÉRIEUX
  • Oxford Immunotec
  • SD Biosensor, INC.
  • Wantai BioPharm
  • Lionex GmbH
  • Sanofi
  • Serum Institute of India Pvt. Ltd
  • ARKRAY, Inc.
  • Par Pharmaceutical, Inc.

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 1.91 Billion
Forecasted Market Value ( USD ) by 2033 $ 3.16 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Latent Tuberculosis Infection Detection - Global Strategic Business Report - Product Image

Latent Tuberculosis Infection Detection - Global Strategic Business Report

  • Report
  • 464 Pages
  • Global
From
Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2025-2030 - Product Image

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Tuberculosis Test Kit Market - Global Forecast 2025-2030 - Product Image

Tuberculosis Test Kit Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Tuberculosis Diagnostics Market Size, Share, Trends and Forecast by Disease Stage, Test Type, End-User, and Region, 2025-2033 - Product Image

Tuberculosis Diagnostics Market Size, Share, Trends and Forecast by Disease Stage, Test Type, End-User, and Region, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.